benzofuroxan has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, RA; Farias, CF; Ferreira, AK; Figueiredo, CR; Girola, N; Jorge, SD; Massaoka, MH; Tavares, LC; Travassos, LR | 1 |
| Azevedo, RA; Barbuto, JA; de Sá Junior, PL; Farias, CF; Ferreira, AC; Ferreira, AK; Figueiredo, CR; Jorge, SD; Kruyt, FA; Palace-Berl, F; Pasqualoto, KF; Rodrigues, CP; Salomón, MA; Tavares, LC; Turra, KM | 1 |
2 other study(ies) available for benzofuroxan and B16 Melanoma
| Article | Year |
|---|---|
Benzofuroxan derivatives N-Br and N-I induce intrinsic apoptosis in melanoma cells by regulating AKT/BIM signaling and display anti metastatic activity in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Benzoxazoles; Cell Line, Tumor; HeLa Cells; Humans; Male; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Oncogene Protein v-akt; Proto-Oncogene Proteins; Signal Transduction | 2015 |
BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.
Topics: Animals; Apoptosis; Benzoxazoles; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Flow Cytometry; Hydrazines; Melanoma, Experimental; Mice; Microscopy, Fluorescence; Molecular Docking Simulation; Oxadiazoles; Proto-Oncogene Proteins B-raf | 2016 |